The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenus Regulatory News (GNS)

Share Price Information for Genus (GNS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,762.00
Bid: 1,760.00
Ask: 1,768.00
Change: -34.00 (-1.89%)
Spread: 8.00 (0.455%)
Open: 1,822.00
High: 1,822.00
Low: 1,750.00
Prev. Close: 1,796.00
GNS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM

15 Nov 2018 16:00

RNS Number : 5250H
Genus PLC
15 November 2018
 

 

Genus plc (the 'Company') - 2018 AGM Poll Results

 

The Company announces that at its AGM held on Thursday, 15 November 2018, all resolutions set out in the Notice of AGM were passed on a poll. 

 

Resolutions 1 to 13 were passed as Ordinary Resolutions and Resolutions 14 to 17 were passed as Special Resolutions. The following table sets out the votes cast on each resolution: 

 

1. To receive the Company's audited Financial Statements and the Directors' Reports for the year ended 30 June 2018.

41,562,922

99.63

155,211

0.37

925,023

41,718,133

2. To approve the Directors' Remuneration Report for the year ended 30 June 2018.

26,732,450

67.93

12,621,755

32.07

3,288,952

39,354,205

3. To declare a final dividend of 17.9 pence per Ordinary Share.

42,641,974

100.00

588

0.00

595

42,642,562

4. To re-elect Bob Lawson as a Director of the Company.

36,048,529

93.32

2,581,420

6.68

4,013,207

38,629,949

5. To re-elect Karim Bitar as a Director of the Company.

42,313,095

99.23

328,680

0.77

1,382

42,641,775

6. To re-elect Stephen Wilson as a Director of the Company.

42,495,775

99.66

145,127

0.34

2,255

42,640,902

7. To re-elect Lysanne Gray as a Director of the Company.

40,256,875

94.41

2,384,900

5.59

1,382

42,641,775

8. To re-elect Lykele van der Broek as a Director of the Company.

40,284,175

94.47

2,357,600

5.53

1,382

42,641,775

9. To elect Lesley Knox as a Director of the Company.

42,192,946

99.66

142,967

0.34

307,242

42,335,913

10. To elect Ian Charles as a Director of the Company.

42,619,061

99.95

19,891

0.05

4,205

42,638,952

11. To re-appoint Deloitte LLP as auditor of the Company.

41,461,219

97.23

1,179,846

2.77

2,091

42,641,065

12. To authorise the Audit Committee of the Board to determine the remuneration of the auditor.

41,881,907

98.23

755,811

1.77

5,439

42,637,718

13. To empower the Directors with limited authority to allot Ordinary Shares.

38,146,650

90.12

4,183,473

9.88

313,032

42,330,123

14. To empower the Directors with limited authority to allot equity securities for cash without first offering them to existing shareholders.

42,586,646

99.92

34,798

0.08

21,713

42,621,444

15. To empower the Directors with limited authority to allot additional equity securities for cash without first offering them to existing shareholders provided that this power be used only in connection with an acquisition or other capital investment.

36,895,601

86.56

5,726,769

13.44

20,786

42,622,370

16. To empower the Directors with limited authority to make one or more market purchases of any Ordinary Shares.

42,108,111

98.96

442,733

1.04

92,312

42,550,844

17. To allow a General Meeting other than an Annual General Meeting to be called on not less than 14 clear days' notice.

40,457,388

94.89

2,178,463

5.11

7,306

42,635,851

 

 

 

A copy of the special business resolutions will be submitted to the National Storage Mechanism and will soon be available to view at http://www.morningstar.co.uk/uk/NSM.

As at the close of business on 14 November 2018, the total number of ordinary shares of £0.10 each eligible to be voted at the AGM was 61,948,505. Therefore, the total voting rights in the Company as at that time were 61,948,505.

Equiniti acted as scrutineer of the poll on all resolutions.

 

Senior Independent Director and Chairman of the Remuneration Committee

 

The Company is pleased to announce that Lesley Knox, Non-Executive Director (appointed June 2018) has been appointed Senior Independent Non-Executive Director and Chairman of the Remuneration Committee, effective immediately. This follows the retirement of Nigel Turner at the AGM earlier today and as previously announced on 24 September 2018. This statement is made in accordance with Listing Rule 9.6.11.

 

AGM - Resolution Two

 

The Board of Genus acknowledges that a number of votes were received from shareholders against Resolution 2, for the approval of the Directors Remuneration Report ("DRR"). It is evident through the feedback that votes against the Resolution were predominantly linked to the one-off adjustment to the CEO salary, which was determined by our Remuneration Committee ("Committee") and for which a detailed justification was made in the DRR.

The Company actively engaged with our top ten shareholders to discuss this change ahead of the publication of the Annual Report and DRR to address any potential concerns.

 

We are aware that reports from a number of shareholder agencies recommended voting against Resolution 2. We were disappointed with these recommendations. The change in CEO salary was designed as a one-off intervention that the Committee believed was both justified and necessary to retain and motivate a very high calibre leader who is steering the transformation of the business, creating significant long-term stakeholder value, and setting the future strategic direction of the Company as it transforms into an agricultural biotechnology pioneer.

 

The Board and Committee take seriously their responsibilities to represent the interests of shareholders and to uphold the highest standards of corporate governance. Our existing Remuneration Policy received strong levels of shareholder support when approved in 2016, and we will put a new Remuneration Policy to shareholders at our 2019 AGM. Ahead of this we will also continue to engage with shareholders on reward, and to consider their views on our existing policy, including the shareholder views being expressed in relation to Resolution 2.

 

Bob Lawson, Chairman of Genus said: "We believe that Karim Bitar's one-off salary realignment is in the best interests of the Company and the justification is clear. The Remuneration Committee takes a highly responsible approach to executive pay and, to date, has enjoyed strong support from our shareholders."

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RAGGGGMAGUPRGCA
Date   Source Headline
1st Feb 20161:22 pmRNSBlocklisting Interim Review
4th Jan 20165:40 pmRNSTotal Voting Rights
11th Dec 20153:14 pmRNSDirector/PDMR Shareholding
9th Dec 20154:30 pmRNSDirector/PDMR Shareholding
8th Dec 20157:00 amRNSTackles major pig disease with breakthrough tech
1st Dec 20154:54 pmRNSHolding(s) in Company
1st Dec 20154:46 pmRNSTotal Voting Rights
19th Nov 20152:52 pmRNSResult of AGM
19th Nov 20157:00 amRNSAGM - TRADING UPDATE
2nd Nov 20153:04 pmRNSTotal Voting Rights
22nd Oct 20155:48 pmRNSHolding(s) in Company
21st Oct 20156:10 pmRNSDirector/PDMR Shareholding
15th Oct 201512:46 pmRNSAnnual Report and Notice of AGM
1st Oct 20153:00 pmRNSTotal Voting Rights
15th Sep 201511:00 amRNSDirector/PDMR Shareholding
8th Sep 20157:00 amRNSPreliminary Results
3rd Aug 20152:00 pmRNSBlocklisting Interim Review
30th Jun 20152:00 pmRNSTotal Voting Rights
29th Jun 20152:00 pmRNSChange of Registered Office
29th May 20152:00 pmRNSTotal Voting Rights
12th May 20157:00 amRNSCapital Markets Event and Trading Update
11th May 20152:00 pmRNSHolding(s) in Company
7th May 20152:21 pmRNSHolding(s) in Company
30th Apr 20152:00 pmRNSTotal Voting Rights
14th Apr 20152:00 pmRNSDirector/PDMR Shareholding
13th Apr 20155:06 pmRNSHolding(s) in Company
1st Apr 20157:00 amRNSCompletion of acquisition
31st Mar 20154:04 pmRNSTotal Voting Rights
19th Mar 20155:46 pmRNSDirector/PDMR Shareholding
12th Mar 20152:09 pmRNSDirector/PDMR Shareholding
9th Mar 20151:24 pmRNSDirector Declaration
27th Feb 20152:00 pmRNSTotal Voting Rights
24th Feb 201511:00 amRNSHolding(s) in Company
24th Feb 20157:00 amRNSInterim Results
16th Feb 20157:00 amRNSAcquisition of 51% of In Vitro Brasil
2nd Feb 20151:22 pmRNSBlock Listing Six Monthly Return
31st Dec 201412:01 pmRNSTotal Voting Rights
12th Dec 201410:44 amRNSDirector/PDMR Shareholding
1st Dec 20144:36 pmRNSTotal Voting Rights
21st Nov 20144:03 pmRNSDirector/PDMR Shareholding
14th Nov 20143:42 pmRNSResult of AGM
14th Nov 20147:00 amRNSTrading Update
31st Oct 201412:20 pmRNSTotal Voting Rights
22nd Oct 20149:29 amRNSDirector/PDMR Shareholding
10th Oct 20145:58 pmRNSHolding(s) in Company
8th Oct 20143:47 pmRNSAnnual Report and Annual General Meeting
3rd Sep 20147:00 amRNSPreliminary Results
3rd Sep 20147:00 amRNSPorcine Multiplication Agreement in China
29th Aug 20143:08 pmRNSTotal Voting Rights
1st Aug 20142:00 pmRNSBlock Listing 6 Monthly Return

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.